Mixed Ru(II)-Ir(III) Complexes As Photoactive Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4

Overview

Journal Inorg Chem

Specialty Chemistry

Date 2024 Sep 16

PMID 39283981

Authors

Justin J Ahrens

Madeline Denison

Santana Garcia

Sayak Gupta

Thomas A Kocarek

Irina F Sevrioukova

Claudia Turro

Jeremy J Kodanko

Affiliations

Soon will be listed here.

Abstract

Cytochrome P450 3A4 (CYP3A4) is a crucial enzyme in human drug metabolism. To garner photochemical control over the inhibition of CYP3A4, a potent Ir(III)-based inhibitor of CYP3A4 was complexed with two Ru(II)-based photocaging groups. Chemical, photochemical, and biological properties of the photocaged inhibitors were characterized. Importantly, mixed Ru(II)-Ir(III) complexes strongly absorb green light, which facilitates the photochemical release of the Ir(III) inhibitor from the Ru(II) caging fragment [Ru(tpy)(Mebpy)], where tpy = 2,2':6',2″-terpyridine and Mebpy = 6,6'-dimethyl-2,2'-bipyridine. Emission turn on, type II heme binding, and more potent inhibition under light vs dark conditions were observed. The study also demonstrated that a Ru(II)-Ir(III) conjugate can be photoactivated to exert cytotoxic effects on MCF-7 breast cancer cells upon green light exposure. Additionally, a synthesized analogue with one [Ru(TPA)] fragment (TPA = tris(pyridin-2-ylmethyl)amine) and two Ir(III) centers, although resistant to photochemical release, showed strong inhibition of CYP3A4 both in purified form and in CYP3A4-overexpressing HepG2 cells, with nanomolar potency. These mixed Ru(II)-Ir(III) compounds can permeate cell membranes and inhibit CYP3A4, presenting a new class of bioactive compounds.

References

Sharma R, Knoll J, Ancona N, Martin P, Turro C, Kodanko J . Solid-phase synthesis as a platform for the discovery of new ruthenium complexes for efficient release of photocaged ligands with visible light. Inorg Chem. 2015; 54(4):1901-11. PMC: 4720264. DOI: 10.1021/ic502791y. View

Li A, Turro C, Kodanko J . Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging. Acc Chem Res. 2018; 51(6):1415-1421. PMC: 6019290. DOI: 10.1021/acs.accounts.8b00066. View

Zamora A, Denning C, Heidary D, Wachter E, Nease L, Ruiz J . Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage. Dalton Trans. 2017; 46(7):2165-2173. DOI: 10.1039/c6dt04405k. View

Respondek T, Garner R, Herroon M, Podgorski I, Turro C, Kodanko J . Light activation of a cysteine protease inhibitor: caging of a peptidomimetic nitrile with Ru(II)(bpy)2. J Am Chem Soc. 2011; 133(43):17164-7. PMC: 4027032. DOI: 10.1021/ja208084s. View

Novohradsky V, Rovira A, Hally C, Galindo A, Vigueras G, Gandioso A . Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir Complex Conjugated to a Far-Red Emitting Coumarin. Angew Chem Int Ed Engl. 2019; 58(19):6311-6315. DOI: 10.1002/anie.201901268. View

Huang K, Jiang C, Marti A . Ascertaining free histidine from mixtures with histidine-containing proteins using time-resolved photoluminescence spectroscopy. J Phys Chem A. 2014; 118(45):10353-8. DOI: 10.1021/jp502837a. View

Huang K, Bulik I, Marti A . Time-resolved photoluminescence spectroscopy for the detection of cysteine and other thiol containing amino acids in complex strongly autofluorescent media. Chem Commun (Camb). 2012; 48(96):11760-2. DOI: 10.1039/c2cc36588j. View

Zhang L, Wang P, Zhou X, Bretin L, Zeng X, Husiev Y . Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors. J Am Chem Soc. 2023; 145(27):14963-14980. PMC: 10347550. DOI: 10.1021/jacs.3c04855. View

Barata I, Gomes B, Rodrigues A, Rueff J, Kranendonk M, Esteves F . The Complex Dynamic of Phase I Drug Metabolism in the Early Stages of Doxorubicin Resistance in Breast Cancer Cells. Genes (Basel). 2022; 13(11). PMC: 9689592. DOI: 10.3390/genes13111977. View

10.

Denison M, Ahrens J, Dunbar M, Warmahaye H, Majeed A, Turro C . Dynamic Ir(III) Photosensors for the Major Human Drug-Metabolizing Enzyme Cytochrome P450 3A4. Inorg Chem. 2023; 62(7):3305-3320. PMC: 10268476. DOI: 10.1021/acs.inorgchem.3c00059. View

11.

van Rixel V, Ramu V, Auyeung A, Beztsinna N, Leger D, Lameijer L . Photo-Uncaging of a Microtubule-Targeted Rigidin Analogue in Hypoxic Cancer Cells and in a Xenograft Mouse Model. J Am Chem Soc. 2019; 141(46):18444-18454. PMC: 11774275. DOI: 10.1021/jacs.9b07225. View

12.

Chen Q, Cuello-Garibo J, Bretin L, Zhang L, Ramu V, Aydar Y . Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model. Chem Sci. 2022; 13(23):6899-6919. PMC: 9200134. DOI: 10.1039/d2sc01646j. View

13.

Ye R, Tan C, He L, Chen M, Ji L, Mao Z . Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy. Chem Commun (Camb). 2014; 50(75):10945-8. DOI: 10.1039/c4cc05215c. View

14.

Lo K . Luminescent Rhenium(I) and Iridium(III) Polypyridine Complexes as Biological Probes, Imaging Reagents, and Photocytotoxic Agents. Acc Chem Res. 2015; 48(12):2985-95. DOI: 10.1021/acs.accounts.5b00211. View

15.

Xiong L, Zhao Q, Chen H, Wu Y, Dong Z, Zhou Z . Phosphorescence imaging of homocysteine and cysteine in living cells based on a cationic iridium(III) complex. Inorg Chem. 2010; 49(14):6402-8. DOI: 10.1021/ic902266x. View

16.

Li A, Yadav R, White J, Herroon M, Callahan B, Podgorski I . Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1. Chem Commun (Camb). 2017; 53(26):3673-3676. PMC: 5468790. DOI: 10.1039/c7cc01459g. View

17.

Chen S, Wu Q, Li X, Li D, Mei N, Ning B . Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity. J Environ Sci Health C Toxicol Carcinog. 2021; 39(1):68-86. PMC: 7931144. DOI: 10.1080/26896583.2021.1880242. View

18.

Li A, White J, Arora K, Herroon M, Martin P, Schlegel H . Selective Release of Aromatic Heterocycles from Ruthenium Tris(2-pyridylmethyl)amine with Visible Light. Inorg Chem. 2015; 55(1):10-2. PMC: 4864085. DOI: 10.1021/acs.inorgchem.5b02600. View

19.

Li A, Turro C, Kodanko J . Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles. Chem Commun (Camb). 2018; 54(11):1280-1290. PMC: 5904840. DOI: 10.1039/c7cc09000e. View

20.

Knoll J, Albani B, Turro C . Excited state investigation of a new Ru(II) complex for dual reactivity with low energy light. Chem Commun (Camb). 2015; 51(42):8777-80. PMC: 4430371. DOI: 10.1039/c5cc01865j. View